PULSED-MULTILINE EXCITATION FOR COLOR-BLIND FLUORESCENCE DETECTION
    1.
    发明申请
    PULSED-MULTILINE EXCITATION FOR COLOR-BLIND FLUORESCENCE DETECTION 有权
    用于彩色荧光检测的脉冲多重激活

    公开(公告)号:US20090156429A1

    公开(公告)日:2009-06-18

    申请号:US12388358

    申请日:2009-02-18

    IPC分类号: C40B30/10 C12Q3/00

    摘要: The present invention provides a technology called Pulse-Multiline Excitation or PME. This technology provides a novel approach to fluorescence detection with application for high-throughput identification of informative SNPs, which could lead to more accurate diagnosis of inherited disease, better prognosis of risk susceptibilities, or identification of sporadic mutations. The PME technology has two main advantages that significantly increase fluorescence sensitivity: (1) optimal excitation of all fluorophores in the genomic assay and (2) “color-blind” detection, which collects considerably more light than standard wavelength resolved detection. Successful implementation of the PME technology will have broad application for routine usage in clinical diagnostics, forensics, and general sequencing methodologies and will have the capability, flexibility, and portability of targeted sequence variation assays for a large majority of the population.

    摘要翻译: 本发明提供了一种称为脉冲 - 多重激发或PME的技术。 该技术提供了一种新的荧光检测方法,可应用于信息性SNP的高通量鉴定,这可以导致对遗传疾病的更准确的诊断,更好的预后风险易感性或散发性突变的鉴定。 PME技术有两个显着增加荧光灵敏度的主要优点:(1)基因组测定中所有荧光团的最佳激发和(2)“色盲”检测,其比标准波长分辨检测收集明显更多的光。 PME技术的成功实施将广泛应用于临床诊断,取证和一般测序方法中的常规应用,并将为大多数人群提供靶向序列变异测定的能力,灵活性和可移植性。

    Pulsed-Multiline Excitation for Color-Blind Fluorescence Detection
    2.
    发明申请
    Pulsed-Multiline Excitation for Color-Blind Fluorescence Detection 审中-公开
    用于彩色荧光检测的脉冲多谱激励

    公开(公告)号:US20120219029A1

    公开(公告)日:2012-08-30

    申请号:US13342471

    申请日:2012-01-03

    IPC分类号: H01S3/00 G02B5/04

    摘要: The present invention provides a technology called Pulse-Multiline Excitation or PME. This technology provides a novel approach to fluorescence detection with application for high-throughput identification of informative SNPs, which could lead to more accurate diagnosis of inherited disease, better prognosis of risk susceptibilities, or identification of sporadic mutations. The PME technology has two main advantages that significantly increase fluorescence sensitivity: (1) optimal excitation of all fluorophores in the genomic assay and (2) “color-blind” detection, which collects considerably more light than standard wavelength resolved detection. Successful implementation of the PME technology will have broad application for routine usage in clinical diagnostics, forensics, and general sequencing methodologies and will have the capability, flexibility, and portability of targeted sequence variation assays for a large majority of the population.

    摘要翻译: 本发明提供了一种称为脉冲 - 多重激发或PME的技术。 该技术提供了一种新的荧光检测方法,可应用于信息性SNP的高通量鉴定,这可以导致对遗传疾病的更准确的诊断,更好的预后风险易感性或散发性突变的鉴定。 PME技术有两个显着增加荧光灵敏度的主要优点:(1)基因组测定中所有荧光团的最佳激发和(2)“色盲”检测,其比标准波长分辨检测收集明显更多的光。 PME技术的成功实施将广泛应用于临床诊断,取证和一般测序方法中的常规应用,并将为大多数人群提供靶向序列变异测定的能力,灵活性和可移植性。

    Pulsed-multiline excitation for color-blind fluorescence detection
    3.
    发明授权
    Pulsed-multiline excitation for color-blind fluorescence detection 失效
    用于彩色盲荧光检测的脉冲多重激发

    公开(公告)号:US06995841B2

    公开(公告)日:2006-02-07

    申请号:US09941165

    申请日:2001-08-28

    IPC分类号: G01J3/30 G01N21/25 F21V9/16

    摘要: The present invention provides a technology called Pulse-Multiline Excitation or PME. This technology provides a novel approach to fluorescence detection with application for high-throughput identification of informative SNPs, which could lead to more accurate diagnosis of inherited disease, better prognosis of risk susceptibilities, or identification of sporadic mutations. The PME technology has two main advantages that significantly increase fluorescence sensitivity: (1) optimal excitation of all fluorophores in the genomic assay and (2) “color-blind” detection, which collects considerably more light than standard wavelength resolved detection. Successful implementation of the PME technology will have broad application for routine usage in clinical diagnostics, forensics, and general sequencing methodologies and will have the capability, flexibility, and portability of targeted sequence variation assays for a large majority of the population.

    摘要翻译: 本发明提供了一种称为脉冲 - 多重激发或PME的技术。 该技术提供了一种新的荧光检测方法,可应用于信息性SNP的高通量鉴定,这可以导致对遗传疾病的更准确的诊断,更好的预后风险易感性或散发性突变的鉴定。 PME技术有两个显着增加荧光灵敏度的主要优点:(1)基因组测定中所有荧光团的最佳激发和(2)“色盲”检测,其比标准波长分辨检测收集明显更多的光。 PME技术的成功实施将广泛应用于临床诊断,取证和一般测序方法中的常规应用,并将为大多数人群提供靶向序列变异测定的能力,灵活性和可移植性。

    Pulsed-multiline excitation for color-blind fluorescence detection
    4.
    发明授权
    Pulsed-multiline excitation for color-blind fluorescence detection 有权
    用于彩色盲荧光检测的脉冲多重激发

    公开(公告)号:US08089628B2

    公开(公告)日:2012-01-03

    申请号:US12388358

    申请日:2009-02-18

    IPC分类号: G01N21/25

    摘要: The present invention provides a technology called Pulse-Multiline Excitation or PME. This technology provides a novel approach to fluorescence detection with application for high-throughput identification of informative SNPs, which could lead to more accurate diagnosis of inherited disease, better prognosis of risk susceptibilities, or identification of sporadic mutations. The PME technology has two main advantages that significantly increase fluorescence sensitivity: (1) optimal excitation of all fluorophores in the genomic assay and (2) “color-blind” detection, which collects considerably more light than standard wavelength resolved detection. Successful implementation of the PME technology will have broad application for routine usage in clinical diagnostics, forensics, and general sequencing methodologies and will have the capability, flexibility, and portability of targeted sequence variation assays for a large majority of the population.

    摘要翻译: 本发明提供了一种称为脉冲 - 多重激发或PME的技术。 该技术提供了一种新的荧光检测方法,可应用于信息性SNP的高通量鉴定,这可以导致对遗传疾病的更准确的诊断,更好的预后风险易感性或散发性突变的鉴定。 PME技术有两个显着增加荧光灵敏度的主要优点:(1)基因组测定中所有荧光团的最佳激发和(2)“色盲”检测,其比标准波长分辨检测收集明显更多的光。 PME技术的成功实施将广泛应用于临床诊断,取证和一般测序方法中的常规应用,并将为大多数人群提供靶向序列变异测定的能力,灵活性和可移植性。

    Pulsed-multiline excitation for color-blind fluorescence detection
    5.
    发明授权
    Pulsed-multiline excitation for color-blind fluorescence detection 有权
    用于彩色盲荧光检测的脉冲多重激发

    公开(公告)号:US07511811B2

    公开(公告)日:2009-03-31

    申请号:US11248910

    申请日:2005-10-12

    IPC分类号: G01J3/30

    摘要: The present invention provides a technology called Pulse-Multiline Excitation or PME. This technology provides a novel approach to fluorescence detection with application for high-throughput identification of informative SNPs, which could lead to more accurate diagnosis of inherited disease, better prognosis of risk susceptibilities, or identification of sporadic mutations. The PME technology has two main advantages that significantly increase fluorescence sensitivity: (1) optimal excitation of all fluorophores in the genomic assay and (2) “color-blind” detection, which collects considerably more light than standard wavelength resolved detection. This technology differs significantly from the current state-of-the-art DNA sequencing instrumentation, which features single source excitation and color dispersion for DNA sequence identification. Successful implementation of the PME technology will have broad application for routine usage in clinical diagnostics, forensics, and general sequencing methodologies and will have the capability, flexibility, and portability of targeted sequence variation assays for a large majority of the population.

    摘要翻译: 本发明提供了一种称为脉冲 - 多重激发或PME的技术。 该技术提供了一种新的荧光检测方法,可应用于信息性SNP的高通量鉴定,这可以导致对遗传疾病的更准确的诊断,更好的预后风险易感性或散发性突变的鉴定。 PME技术有两个显着增加荧光灵敏度的主要优点:(1)基因组测定中所有荧光团的最佳激发和(2)“色盲”检测,其比标准波长分辨检测收集明显更多的光。 该技术与目前最先进的DNA测序仪器显着不同,其具有用于DNA序列鉴定的单源激发和色散。 PME技术的成功实施将广泛应用于临床诊断,取证和一般测序方法中的常规应用,并将为大多数人群提供靶向序列变异测定的能力,灵活性和可移植性。

    Pulsed-multiline excitation for color-blind fluorescence detection

    公开(公告)号:US20060139634A1

    公开(公告)日:2006-06-29

    申请号:US11248910

    申请日:2005-10-12

    IPC分类号: G01J3/30

    摘要: The present invention provides a technology called Pulse-Multiline Excitation or PME. This technology provides a novel approach to fluorescence detection with application for high-throughput identification of informative SNPs, which could lead to more accurate diagnosis of inherited disease, better prognosis of risk susceptibilities, or identification of sporadic mutations. The PME technology has two main advantages that significantly increase fluorescence sensitivity: (1) optimal excitation of all fluorophores in the genomic assay and (2) “color-blind” detection, which collects considerably more light than standard wavelength resolved detection. This technology differs significantly from the current state-of-the-art DNA sequencing instrumentation, which features single source excitation and color dispersion for DNA sequence identification. Successful implementation of the PME technology will have broad application for routine usage in clinical diagnostics, forensics, and general sequencing methodologies and will have the capability, flexibility, and portability of targeted sequence variation assays for a large majority of the population.